Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Rheumatic Disorders Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rheumatic Disorders Drugmarket, defines the market attractiveness level of Rheumatic Disorders Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rheumatic Disorders Drug industry, describes the types of Rheumatic Disorders Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rheumatic Disorders Drug market and the development prospects and opportunities of Rheumatic Disorders Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rheumatic Disorders Drug market in Chapter 13.
By Player:
Bristol-Myers Squibb
Roche
Novartis
AbbVie
Amgen
Johnson & Johnson
Pfizer
Eli Lilly
By Type:
Acting on Tumor Necrosis Factor-Alpha
Acting on Interleukins and Interleukin Receptors
Acting on Protein Kinases
Acting on Cell Surface Antigens
Acting on Hormones and Hormone Receptors
Others
By End-User:
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Systemic Lupus Erythematosus
Psoriatic Arthritis
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rheumatic Disorders Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rheumatic Disorders Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rheumatic Disorders Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rheumatic Disorders Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rheumatic Disorders Drug Market Analysis and Outlook to 2022
-
7.1 Global Rheumatic Disorders Drug Consumption (2017-2022)
-
7.2 United States Rheumatic Disorders Drug Consumption (2017-2022)
-
7.3 Europe Rheumatic Disorders Drug Consumption (2017-2022)
-
7.4 China Rheumatic Disorders Drug Consumption (2017-2022)
-
7.5 Japan Rheumatic Disorders Drug Consumption (2017-2022)
-
7.6 India Rheumatic Disorders Drug Consumption (2017-2022)
-
7.7 South Korea Rheumatic Disorders Drug Consumption (2017-2022)
8 Region and Country-wise Rheumatic Disorders Drug Market Analysis and Outlook to 2028
-
8.1 Global Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.2 United States Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.3 Europe Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.4 China Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.5 Japan Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.6 India Rheumatic Disorders Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Rheumatic Disorders Drug Consumption Forecast (2022-2028)
9 Global Rheumatic Disorders Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Rheumatic Disorders Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Acting on Tumor Necrosis Factor-Alpha Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Acting on Interleukins and Interleukin Receptors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Acting on Protein Kinases Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Acting on Cell Surface Antigens Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Acting on Hormones and Hormone Receptors Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Rheumatic Disorders Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Osteoporosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Rheumatic Disorders Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Rheumatic Disorders Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Acting on Tumor Necrosis Factor-Alpha Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Acting on Interleukins and Interleukin Receptors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Acting on Protein Kinases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Acting on Cell Surface Antigens Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Acting on Hormones and Hormone Receptors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rheumatic Disorders Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Rheumatic Disorders Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rheumatic Disorders Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rheumatic Disorders Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rheumatic Disorders Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rheumatic Disorders Drug Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Rheumatic Disorders Drug Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Rheumatic Disorders Drug Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Rheumatic Disorders Drug Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Rheumatic Disorders Drug Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Rheumatic Disorders Drug Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Rheumatic Disorders Drug Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Rheumatic Disorders Drug Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Rheumatic Disorders Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rheumatic Disorders Drug
-
Figure Rheumatic Disorders Drug Picture
-
Table Global Rheumatic Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatic Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatic Disorders Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rheumatic Disorders Drug Consumption by Country (2017-2022)
-
Figure United States Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure China Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure India Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rheumatic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatic Disorders Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rheumatic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acting on Tumor Necrosis Factor-Alpha Consumption and Growth Rate (2017-2022)
-
Figure Global Acting on Interleukins and Interleukin Receptors Consumption and Growth Rate (2017-2022)
-
Figure Global Acting on Protein Kinases Consumption and Growth Rate (2017-2022)
-
Figure Global Acting on Cell Surface Antigens Consumption and Growth Rate (2017-2022)
-
Figure Global Acting on Hormones and Hormone Receptors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoporosis Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Acting on Tumor Necrosis Factor-Alpha Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acting on Interleukins and Interleukin Receptors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acting on Protein Kinases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acting on Cell Surface Antigens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acting on Hormones and Hormone Receptors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rheumatic Disorders Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rheumatic Disorders Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Rheumatic Disorders Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Rheumatic Disorders Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Rheumatic Disorders Drug Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Rheumatic Disorders Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Rheumatic Disorders Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Rheumatic Disorders Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Rheumatic Disorders Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Rheumatic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Rheumatic Disorders Drug Product and Service
-
